Workflow
PolyPid(PYPD)
icon
Search documents
PolyPid(PYPD) - 2024 Q1 - Earnings Call Transcript
2024-05-10 02:38
PolyPid Ltd (NASDAQ:PYPD) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Brian Ritchie - IR Dikla Czaczkes Akselbrad - CEO & Director Jonny Missulawin - Chief Financial Officer Ori Warshavsky - Chief Operating Officer, US Conference Call Participants Roy Buchanan - JMP Operator Thank you all for participating in PolyPid's First Quarter 2024 Earnings Conference Call. Joining me on the call today will be Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid; Jonny Missulaw ...
PolyPid(PYPD) - 2023 Q4 - Annual Report
2024-03-06 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANTTO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission ...
PolyPid(PYPD) - 2023 Q4 - Earnings Call Transcript
2024-02-14 16:13
PolyPid Ltd (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript February 14, 2024 8:30 AM ET Company Participants Brian Ritchie - IR Dikla Czaczkes Akselbrad - CEO & Director Jonny Missulawin - Chief Financial Officer Conference Call Participants Roy Buchanan - JMP Boobalan Pachaiyappan - HC Wainwright Operator Greeting morning and welcome to the PolyPid Fourth Quarter and Full Year 2023 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded. And I ...
PolyPid(PYPD) - 2023 Q3 - Earnings Call Transcript
2023-11-12 06:08
PolyPid Ltd. (NASDAQ:PYPD) Q3 2023 Earnings Conference Call November 11, 2023 8:00 AM ET In fact, as we said would be the case by this time, we currently have approximately 20 centers open, the majority of which are outside of Israel. The vast majority of these 20 centers have opened only in the last few weeks. Therefore, while we currently have approximately 50 patients recruited into the SHIELD II trial, we expect enrollment to ramp up shortly. To this end, we anticipate having approximately 40 centers op ...
PolyPid(PYPD) - 2023 Q2 - Earnings Call Transcript
2023-08-09 16:55
PolyPid Ltd (NASDAQ:PYPD) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Brian Ritchie - LifeSci Advisors Dikla Akselbrad - CEO & Director Jonny Missulawin - CFO Ori Warshavsky - COO Douglas Buchanan - JMP Securities Greetings, and welcome to the PolyPid Second Quarter 2023 Conference Call. Brian Ritchie Earlier today, PolyPid released financial results for the 3 and 6 months ended June 30, 2023. A copy of the press release is available in the Investors section on the company's website, www.poly ...
PolyPid(PYPD) - 2023 Q1 - Earnings Call Presentation
2023-05-11 15:08
Executive Vice President heading R&D, and Clinical & Regulatory Affairs Balance Sheet • An early stop to the trial can occur if the efficacy of DPLEX100 is better than expected • Opportunity to define the targeted patient enrollment range for the SHIELD I study 5 Total US addressable market (TAM) for D-PLEX100 is over 12.2M procedures Number of surgeries in DPLEX target indications (M) 4.42 12.15 2.44 0.47 4.82 Abdominal Gyn & Uro Sternum Orthopedic Total | --- | --- | |-------|----------------------------- ...
PolyPid(PYPD) - 2023 Q1 - Earnings Call Transcript
2023-05-10 16:50
PolyPid Ltd. (NASDAQ:PYPD) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors Dikla Czaczkes Akselbrad - Chief Executive Officer Jonny Missulawin - Chief Financial Officer Ori Warshavsky - Chief Operating Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Roy Buchanan - JMP Securities Operator Greetings, and welcome to the PolyPid First Quarter 2023 Conference Call. At this time participants are in a listen-only mode. As a remi ...
PolyPid(PYPD) - 2023 Q1 - Quarterly Report
2023-03-31 20:49
Exhibit 99.2 POLYPID LTD. PETACH TIKVA, ISRAEL PROXY STATEMENT ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 5, 2023 The enclosed proxy is being solicited by the board of directors (the "Board of Directors") of PolyPid Ltd. (the "Company") for use at the Company's annual and extraordinary general meeting of shareholders (the "Meeting") to be held on May 5, 2023, at 2:00 p.m. Israel time, or at any adjournment or postponement thereof. Upon the receipt of a properly executed proxy ...
PolyPid(PYPD) - 2022 Q4 - Annual Report
2023-03-31 19:53
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANTTO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission ...
PolyPid(PYPD) - 2022 Q4 - Earnings Call Transcript
2023-02-08 18:20
PolyPid Ltd (NASDAQ:PYPD) Q4 2022 Earnings Conference Call February 8, 2023 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors Dikla Akselbrad - CEO Ori Warshavsky - COO, US Jonny Missulawin - SVP, Finance Conference Call Participants Brandon Folkes - Cantor Fitzgerald Douglas Buchanan - JMP Securities Operator Greetings, and welcome to the PolyPid Fourth Quarter and Full Year 2022 Conference Call. [Operator Instructions]. As a reminder, this call is recorded. And I would now like to introduc ...